DE69820449D1 - T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen - Google Patents

T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen

Info

Publication number
DE69820449D1
DE69820449D1 DE69820449T DE69820449T DE69820449D1 DE 69820449 D1 DE69820449 D1 DE 69820449D1 DE 69820449 T DE69820449 T DE 69820449T DE 69820449 T DE69820449 T DE 69820449T DE 69820449 D1 DE69820449 D1 DE 69820449D1
Authority
DE
Germany
Prior art keywords
cell
tirc7
membrane protein
antibodies
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69820449T
Other languages
English (en)
Other versions
DE69820449T2 (de
Inventor
Nalan Utku
R Gullans
L Milford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Utku Nalan Dr 10719 Berlin De
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19738710A external-priority patent/DE19738710A1/de
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Priority to DE69820449T priority Critical patent/DE69820449T2/de
Application granted granted Critical
Publication of DE69820449D1 publication Critical patent/DE69820449D1/de
Publication of DE69820449T2 publication Critical patent/DE69820449T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
DE69820449T 1997-08-29 1998-08-28 T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen Expired - Lifetime DE69820449T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69820449T DE69820449T2 (de) 1997-08-29 1998-08-28 T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19738710A DE19738710A1 (de) 1997-08-29 1997-08-29 Verwendung von TIRC7 zur Herstellung von Mitteln zur Inhibition der Immunantwort
DE19738710 1997-08-29
DE29802653 1998-02-12
DE29802653U 1998-02-12
PCT/EP1998/005462 WO1999011782A1 (en) 1997-08-29 1998-08-28 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
DE69820449T DE69820449T2 (de) 1997-08-29 1998-08-28 T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen

Publications (2)

Publication Number Publication Date
DE69820449D1 true DE69820449D1 (de) 2004-01-22
DE69820449T2 DE69820449T2 (de) 2005-03-10

Family

ID=26039678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820449T Expired - Lifetime DE69820449T2 (de) 1997-08-29 1998-08-28 T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen

Country Status (10)

Country Link
EP (2) EP1350848A3 (de)
JP (1) JP4459435B2 (de)
AT (1) ATE256185T1 (de)
AU (1) AU751151C (de)
CA (1) CA2301499C (de)
DE (1) DE69820449T2 (de)
DK (1) DK0996726T3 (de)
ES (1) ES2213295T3 (de)
PT (1) PT996726E (de)
WO (1) WO1999011782A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
ATE399019T1 (de) * 2000-05-03 2008-07-15 Cellact Pharma Gmbh Verwendungen von tgap7 zur modulation der aktivierung von leukozyten
EP1353687B1 (de) * 2000-10-30 2006-07-26 GenPat77 Pharmacogenetics AG Verfahren zur gewinnung von inhibitoren der tirc7-liganden-bindung und verwendungszwecke dafür
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
WO2003025000A2 (en) * 2001-09-17 2003-03-27 Nalan Utku Peptides capable of modulating immune response
EP1448227A2 (de) * 2001-11-27 2004-08-25 GenPat77 Pharmacogenetics AG Verwendung von "t cell immune response cdna7" (tirc7) zur modulierung der angiogenese und/oder der neovaskularisation
EP1492818B1 (de) * 2001-12-21 2012-08-08 CellAct Pharma GmbH Anti-tirc7 antikörper und tnf-alpha antagonisten zur kombinationstherapie von inflammatorischen erkrankungen
WO2003054019A2 (en) * 2001-12-21 2003-07-03 Genpat77 Pharmacogenetics Ag Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases
US20060165689A1 (en) * 2002-02-04 2006-07-27 Nalan Utku Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
WO2003091285A1 (en) * 2002-04-26 2003-11-06 Genpat77 Pharmacogenetics Ag Bispecific molecules for use in therapy and diagnosis of immune related and other diseases
CA2484182A1 (en) * 2002-04-29 2003-11-13 Genpat77 Pharmacogenetics Ag Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
US20110183921A1 (en) * 2005-05-17 2011-07-28 Jojomed Gmbh Peptides capable of modulating the function of tirc7
WO2006122791A2 (en) * 2005-05-17 2006-11-23 Genpat77 Pharmacogenetics Ag Tirc7 as marker for detecting early immune activation
DE202011103324U1 (de) 2011-07-12 2012-01-02 Nekonal S.A.R.L. Therapeutische anti-TIRC7 Antikörper für die Verwendung in Immun und anderen Krankheiten
EP3496745A1 (de) 2016-08-09 2019-06-19 Nekonal S.A.R.L. Auf tirc7 basierende diagnose und therapie von krebs
AU2017309985A1 (en) 2016-08-10 2019-02-28 Nekonal S.A.R.L. TIRC7 based diagnostic and therapy of solid cancer
US20220288120A1 (en) 2019-08-14 2022-09-15 Nekonal S.A.R.L. Method for producing engineered tirc7 specific t-regulatory cells (tregs)

Also Published As

Publication number Publication date
ES2213295T3 (es) 2004-08-16
EP1350848A3 (de) 2004-02-04
DE69820449T2 (de) 2005-03-10
CA2301499A1 (en) 1999-03-11
ATE256185T1 (de) 2003-12-15
AU751151B2 (en) 2002-08-08
JP4459435B2 (ja) 2010-04-28
AU9265498A (en) 1999-03-22
DK0996726T3 (da) 2004-04-13
EP0996726B1 (de) 2003-12-10
EP1350848A2 (de) 2003-10-08
CA2301499C (en) 2010-01-26
WO1999011782A1 (en) 1999-03-11
PT996726E (pt) 2004-04-30
JP2001514852A (ja) 2001-09-18
EP0996726A1 (de) 2000-05-03
AU751151C (en) 2006-09-14

Similar Documents

Publication Publication Date Title
DE69820449D1 (de) T-zell-membranprotein (tirc7), davon abgeleitete peptide und antikörper und ihre verwendungen
DE68916932T2 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
NO20025153D0 (no) FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
DE69636938D1 (de) HYBRID AUS INTERFERON-alpha UND IMMUNGLOBULIN Fc-FRAGMENT VERBUNDEN DURCH EIN NICHT IMMUNOGENES PEPTID
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
WO2001043693A3 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
AUPR775401A0 (en) Novel Epitopes and Uses Thereof
WO1999042127A3 (en) Receptor derived peptides as modulators of receptor activity
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK0972781T3 (da) Protein S-polypeptider og anvendelser deraf
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
NO20011263D0 (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
ATE234358T1 (de) Peptide des pferdearteritisvirus, antikörper und ihre verwendung in einem diagnostischen test
ATE338063T1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers
DE60335278D1 (de) Hen peptiden zur modulierung von ncam funktionen
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE BRIGHAM AND WOMEN'S HOSPITAL INC., BOSTON, MAS

Owner name: UTKU, NALAN, DR., 10719 BERLIN, DE

8328 Change in the person/name/address of the agent

Representative=s name: KOENIG SZYNKA TILMANN VON RENESSE, 40549 DUESSELDO